New Approach to Treating Mesothelioma May Improve Prognosis and Survival Rates
December 4, 2013 – Receptor tyrosine kinases are proteins in the body that play a role in the development, growth and progression of various cancers, including mesothelioma. Researchers from the New York University Langone Medical Center recently studied how a specific receptor tyrosine kinase called Ephrin B2 (EPHB2) affects mesothelioma tumors and cell lines. The […]